**Update 5/9/12

The FDA has issued warning letters to various companies to cease production of products containing 1,3-dimethylamylamine, methylhexanamine, or geranium extract. The FDA says the following:

The agency has received 42 adverse event reports on products containing DMAA. While the complaints do not establish that [...]